+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Gamma Knife Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 184 Pages
  • November 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666137
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Gamma Knife market is transforming radiosurgery practices for healthcare enterprises, as senior stakeholders increasingly prioritize advanced solutions to improve clinical outcomes and operational workflows. Strategic investments in innovative sourcing and adaptive deployment have become imperative for organizations seeking resilience and sustainable competitive advantage in an evolving healthcare environment.

Market Snapshot: Gamma Knife Market Growth and Opportunity

The Gamma Knife market shows robust global growth, with market value anticipated to rise from USD 374.91 million in 2024 to USD 401.05 million in 2025, ultimately projected to reach USD 648.68 million by 2032. This progression, driven by a compound annual growth rate of 7.09%, highlights ongoing traction among healthcare providers. Uptake is fueled by expanding clinical indications, rising demand for precision radiosurgery in neurological and oncological applications, and sustained progress in both reimbursement and funding channels. Evolving clinical standards and dynamic regulatory policies further shape the landscape, as organizations strive to respond effectively to both provider needs and competitive pressures.

Scope & Segmentation: Gamma Knife Radiosurgery Systems Landscape

  • Distribution Channels: Providers utilize direct sales, procurement platforms, partnerships with original equipment manufacturer (OEM) representatives, and regional distributor collaborations. Each channel supports unique procurement priorities within healthcare networks and organizations.
  • End Users: Gamma Knife technology is deployed by a wide range of users, including hospitals, ambulatory surgical centers, neurosurgery departments, specialty clinics, as well as radiology and oncology centers. This reach supports the integration of technology across numerous clinical settings, fostering collaborative, cross-disciplinary care pathways.
  • Applications: Core applications encompass brain tumor management, movement disorders, trigeminal neuralgia, and therapies for vascular abnormalities. Ongoing research and development activities are accelerating adoption in new and adjacent therapeutic areas, strengthening the relevance of Gamma Knife systems in broader treatment contexts.
  • Product Types: Available models such as 4C, Icon, Model C, and Perfexion allow decision-makers to select between new system installations and upgrade pathways. This flexibility ensures system compatibility with existing workflows and organizational standards, supporting both incremental and large-scale deployments.
  • Regions: Global market reach includes the Americas, Europe, Middle East & Africa, and Asia-Pacific. Countries like the United States, Germany, China, India, and Brazil are prominent innovation hubs, enabling rapid technology diffusion while emerging markets drive incremental installation and system uptake.
  • Industry Participants: Major companies including Elekta AB (publ), Accuray Incorporated, Siemens Healthineers AG, Varian Medical Systems, Brainlab AG, ViewRay, Nordion, Mevion Medical Systems, IBA Group, and Shinva Medical Instrument fuel technological advancement and reinforce the sector’s competitive landscape.

Key Takeaways: Strategic Insights for Decision-Makers

  • Enhancing radiosurgery capacity allows healthcare providers to address complex cases and fosters interdisciplinary engagement across clinical teams.
  • Incorporating advanced imaging and machine learning solutions improves the precision and reliability of clinical results, benefiting both established and developing providers.
  • Adopting flexible procurement models enables organizations to respond to regulatory changes and maintain operational agility in a mutable market.
  • Focused investments in workforce training and robust system servicing frameworks accelerate effective system adoption and support collaborative, high-quality clinical practice.
  • Customizing procurement and reimbursement strategies empowers organizations to scale deployments efficiently and align with varying policy requirements across different geographies.
  • Utilizing modular Gamma Knife platforms supports seamless adaptation to evolving technologies, changing patient profiles, and shifting clinical demands with minimal disruption to workflows.

Tariff Impact: Navigating the U.S. 2025 Policy Landscape

Recent U.S. tariff changes are influencing the Gamma Knife supply chain and cost structures. Leading manufacturers are prioritizing localized production and innovative procurement methods to ensure supply continuity. Healthcare providers have responded by expanding supplier networks and reinforcing service reliability. These measures underscore the need for resilient sourcing and effective supplier management as regulatory terrains shift.

Methodology & Data Sources

This research synthesizes insights from direct interviews with neurosurgeons, procurement leaders, and distribution managers, alongside extensive analysis of clinical trials, regulatory filings, and current healthcare policy updates. Triangulation across these sources strengthens the accuracy and actionable value of the recommendations.

Why This Report Matters

  • Executives gain objective benchmarks for performance assessment, supported by integration models that deliver both operational and clinical enhancements.
  • The report delivers actionable guidance for best practices in procurement, compliance, and risk management, empowering informed, strategic decision-making.
  • Ongoing analysis of technology trends and supplier strategies provides leaders with tools to reinforce market position and support sustainable growth within radiosurgery and oncology domains.

Conclusion

Continual adaptation to technology and policy shifts is essential for maintaining quality of care and competitive advantage in the Gamma Knife market. Proactive strategies and agile operating models position organizations for sustainable, long-term success.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Increasing adoption of frameless stereotactic techniques to improve patient comfort and workflow efficiency
5.2. Integration of artificial intelligence algorithms for real time dose planning and adaptive treatment optimization
5.3. Expansion of gamma knife indications to include non malignant neurological disorders such as trigeminal neuralgia
5.4. Development of focused beam collimation technologies to reduce radiation exposure to healthy brain tissue
5.5. Growing preference for outpatient gamma knife radiosurgery due to cost reduction and shorter recovery times
5.6. Collaborative research initiatives between academic centers and manufacturers to advance precision radiosurgery outcomes
5.7. Regulatory approvals and reimbursement reforms facilitating wider gamma knife access in emerging markets
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Gamma Knife Market, by Distribution Channel
8.1. Direct Sales
8.1.1. E Commerce
8.1.2. Oem Sales Team
8.2. Distributor
8.2.1. Local Distributors
8.2.2. National Distributors
9. Gamma Knife Market, by End User
9.1. Ambulatory Surgical Centers
9.1.1. Radiology Centers
9.1.2. Surgical Centers
9.2. Hospitals
9.2.1. Community Hospitals
9.2.2. Tertiary Care Hospitals
9.3. Specialty Clinics
9.3.1. Neurosurgery Centers
9.3.2. Oncology Clinics
10. Gamma Knife Market, by Application
10.1. Brain Tumors
10.1.1. Metastatic Brain Tumors
10.1.2. Primary Brain Tumors
10.2. Functional Disorders
10.2.1. Movement Disorders
10.2.2. Trigeminal Neuralgia
10.3. Vascular Malformations
10.3.1. Arteriovenous Malformations
10.3.2. Cavernous Malformations
11. Gamma Knife Market, by Product Type
11.1. 4C
11.1.1. New Units
11.1.2. Upgrades
11.2. Icon
11.2.1. New Units
11.2.2. Upgrades
11.3. Model C
11.3.1. New Units
11.3.2. Upgrades
11.4. Perfexion
11.4.1. New Units
11.4.2. Upgrades
12. Gamma Knife Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Gamma Knife Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Gamma Knife Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Elekta AB (publ)
15.3.2. Accuray Incorporated
15.3.3. Siemens Healthineers AG
15.3.4. Varian Medical Systems, Inc.
15.3.5. Brainlab AG
15.3.6. ViewRay, Inc.
15.3.7. Nordion Inc.
15.3.8. Mevion Medical Systems, Inc.
15.3.9. IBA Group S.A.
15.3.10. Shinva Medical Instrument Co., Ltd.

Companies Mentioned

The companies profiled in this Gamma Knife market report include:
  • Elekta AB (publ)
  • Accuray Incorporated
  • Siemens Healthineers AG
  • Varian Medical Systems, Inc.
  • Brainlab AG
  • ViewRay, Inc.
  • Nordion Inc.
  • Mevion Medical Systems, Inc.
  • IBA Group S.A.
  • Shinva Medical Instrument Co., Ltd.

Table Information